Eloxx Pharmaceuticals, Inc. financial data

Location
480 Arsenal Way, Suite 130, Watertown, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2023 - Nov 13, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 43 % -78.8%
Debt-to-equity -321 % -184%
Return On Equity 248 %
Return On Assets -203 % -80.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.14M shares -96.4%
Common Stock, Shares, Outstanding 2.17M shares -97.5%
Common Stock, Value, Issued 31K USD -96.4%
Weighted Average Number of Shares Outstanding, Basic 2.75M shares +26.8%
Weighted Average Number of Shares Outstanding, Diluted 2.75M shares +26.8%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 8.92M USD -23.7%
Operating Income (Loss) -19.3M USD +51.8%
Net Income (Loss) Attributable to Parent -20.5M USD +51%
Earnings Per Share, Basic -9 USD/shares +62.2%
Earnings Per Share, Diluted -9 USD/shares +62.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.78M USD -80.6%
Assets, Current 5.63M USD -78.1%
Property, Plant and Equipment, Net 107K USD -50.2%
Operating Lease, Right-of-Use Asset 306K USD -69.2%
Assets 6.04M USD -77.5%
Accounts Payable, Current 3.13M USD +96.5%
Employee-related Liabilities, Current 122K USD -74.8%
Accrued Liabilities, Current 2.44M USD -46%
Liabilities, Current 23.5M USD +8.24%
Operating Lease, Liability, Noncurrent 3K USD -99.1%
Liabilities 26.1M USD -18.1%
Retained Earnings (Accumulated Deficit) -289M USD -7.64%
Stockholders' Equity Attributable to Parent -20M USD -302%
Liabilities and Equity 6.04M USD -77.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.81M USD +28.2%
Net Cash Provided by (Used in) Financing Activities -7.5M USD -207%
Net Cash Provided by (Used in) Investing Activities 11K USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 3.07M shares -96.5%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.3M USD -472%
Interest Paid, Excluding Capitalized Interest, Operating Activities 430K USD +44.8%
Depreciation 71K USD -40.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Property, Plant and Equipment, Gross 331K USD -16.8%
Operating Lease, Liability, Current 315K USD -54.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 2.4M USD -25.9%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%